Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication BeliefsWILEMAN, Vari; CHILCOT, Joseph; NORTON, Sam et al.The Nephron journals. 2011, Vol 119, Num 3, issn 1660-8151, C205-C213Article

SevelamerHENDERSON, Jane; ALTMANN, Paul.Nephron. 2003, Vol 94, Num 3, pp c53-c58, issn 0028-2766Article

Hyperphosphatemia and phosphate binders: effectiveness and safetyKALAITZIDIS, Rigas G; ELISAF, Moses S.Current medical research and opinion. 2014, Vol 30, Num 1, pp 109-112, issn 0300-7995, 4 p.Article

Safety and efficacy of Sevelamer in the treatment of uncontrolled hyperphosphataemia of haemodialysis patientsALMIRALL, Jaume; LOPEZ, Thaïs; VALLVE, Montserrat et al.Nephron. 2004, Vol 97, Num 1, pp c17-c22, issn 0028-2766Article

Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis ― a systematic review and meta-analysis of randomized controlled trialsWENHUI HUANG; JING LIU; YU TANG et al.Current medical research and opinion. 2014, Vol 30, Num 1, pp 99-108, issn 0300-7995, 10 p.Article

Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled TrialsNAVANEETHAN, Sankar D; PALMER, Suetonia C; CRAIG, Jonathan C et al.American journal of kidney diseases. 2009, Vol 54, Num 4, pp 619-637, issn 0272-6386, 19 p.Article

Phosphate Binder Impact on Bone Remodeling and Coronary Calcification -Results from the BRiC StudyVEIT BARRETO, Daniela; DE CARVALHO BARRETO, Fellype; SANTOS, Raul D et al.The Nephron journals. 2008, Vol 110, Num 4, issn 1660-8151, c273-c283Article

Non-Calcium-Containing Phosphate Binders: Comparing Efficacy, Safety, and Other Clinical EffectsFRAZAO, Joao M; ADRAGAO, Teresa.The Nephron journals. 2012, Vol 120, Num 2, issn 1660-8151, c108-c119Article

Sevelamer hydrochloride: an effective phosphate binder in dialyzed childrenMAHDAVI, Homa; KUIZON, Beatriz D; GALES, Barbara et al.Pediatric nephrology (Berlin, West). 2003, Vol 18, Num 12, pp 1260-1264, issn 0931-041X, 5 p.Article

Frequency of elevated serum aluminum levels in adult dialysis patientsJAFFE, Jared A; LIFTMAN, Carol; GLICKMAN, Joel D et al.American journal of kidney diseases. 2005, Vol 46, Num 2, pp 316-319, issn 0272-6386, 4 p.Article

Lack of Correlation between Calcium Intake and Serum Calcium Levels in Stable Haemodialysis SubjectsBYRNE, Fiona N; KINSELLA, Sinead; MURNAGHAN, DermotJ et al.The Nephron journals. 2009, Vol 113, Num 3, issn 1660-8151, c162-c168Article

Tissue Accumulation of Lanthanum as Compared to Aluminum in Rats with Chronic Renal Failure ― Possible Harmful Effects after Long-Term ExposureNIKOLOV, Igor G; JOKI, Nobuhiko; LACOUR, Bernard et al.The Nephron journals. 2010, Vol 115, Num 4, issn 1660-8151, e112-e121Article

Accumulation of metals and minerals from phosphate bindersMOLONY, Donald A; MURTHY, Bhamidipati.Blood purification. 2005, Vol 23, pp 2-11, issn 0253-5068, 10 p., SUP1Article

The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?COZZOLINO, Mario; MAZZAFERRO, Sandro; BRANDENBURG, Vincent et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 2, pp 402-407, issn 0931-0509, 6 p.Article

Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis?VEIGHEY, Kristin; BOOTH, John; DAVENPORT, Andrew et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 3, pp 1006-1010, issn 0931-0509, 5 p.Article

Phosphate : despite advances in research, the benefits to patients remain limitedDE BROE, Marc E.Kidney international. 2009, Vol 75, Num 9, pp 880-881, issn 0085-2538, 2 p.Article

A bitter pill to swallowDAVID, S; MERSCHER, S; SCHMIDT-GUERTLER, H et al.Clinical nephrology. 2009, Vol 72, Num 4, pp 319-321, issn 0301-0430, 3 p.Article

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney diseaseISAKOVA, Tamara; GUTIERREZ, Orlando M; SMITH, Kelsey et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 2, pp 584-591, issn 0931-0509, 8 p.Article

Oral phosphate binders: History and prospectsKAZAMA, Junichiro James.Bone (New York, NY). 2009, Vol 45, issn 8756-3282, S8-S12, SUP1Article

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. CommentarySILVER, J; SUKI, W. N; BLAIR, A. T et al.Kidney international. 2007, Vol 72, Num 9, issn 0085-2538, 1041-1043, 1130-1137 [11 p.]Article

Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in haemodialysis patients: a double-blind, placebo-controlled, short-term trialKURIHARA, Satoshi; TSURUTA, Yoshinari; AKIZAWA, Tadao et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 2, pp 424-430, issn 0931-0509, 7 p.Article

Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patientsDATE, Toshiyuki; SHIGEMATSU, Takashi; KAWASHITA, Yoshiteru et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp iii90-iii93, issn 0931-0509, SUP3Conference Paper

Systemic lanthanum is excreted in the bile of ratsDAMMENT, Stephen J. P; PENNICK, Michael.Toxicology letters. 2007, Vol 171, Num 1-2, pp 69-77, issn 0378-4274, 9 p.Article

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burdenHUTCHISON, Alastair J; LAVILLE, Maurice.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 11, pp 3677-3684, issn 0931-0509, 8 p.Article

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamerRUSSO, D; MIRANDA, I; RUOCCO, C et al.Kidney international. 2007, Vol 72, Num 10, pp 1255-1261, issn 0085-2538, 7 p.Article